Scanning Medical Journals
No new significant updates or guidelines matching this topic were found today. We will check again soon.
MSKCC PCNSL: Two-factor prognostic model for Primary CNS Lymphoma. Simple and validated independently of therapy type.
MSKCC Risk Class
Median Overall Survival
Favorable clinical profile. Intensive therapy often achieves long-term durability in this class.
Verified
Last Review: 2026
Last Comprehensive Review: 2026
